Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by wannaberichguy7on Oct 22, 2018 3:19pm

150 Views

Post# 28850415

no matter..

Red doesnt make me change my mind on this company. In the end if your looking long this company has dipped its toes into the US market and Canadian market . It will run , soon enough if you decide to hold . is there anyone that can tell me why this thing wont run ? Cause i cant seem to see why it wouldnt besides maybe going bankrupt or being pushed out the market.

Bullboard Posts

Eminent acquires promising Nevada gold project